下调和上调
FOXO3公司
黑素细胞
白癜风
染色质免疫沉淀
小眼畸形相关转录因子
关贸总协定3
免疫印迹
癌症研究
荧光素酶
转录因子
生物
细胞生物学
分子生物学
化学
发起人
基因表达
转染
免疫学
细胞培养
黑色素瘤
基因
生物化学
遗传学
作者
Xiaojuan Nie,Lamei Chen,Baihe Wang,Shengnan Wang,Yuan‐Yuan Li
标识
DOI:10.1096/fj.202400676rr
摘要
Abstract Vitiligo is characterized by the depletion of melanocytes due to the activation of CD8 + T cells. Taurine‐upregulated gene 1 (TUG1), a long noncoding RNA, is involved in melanogenesis. This study aimed to explore the role and mechanism of TUG1 in vitiligo. RT‐qPCR and western blot analyses demonstrated decreased TUG1 levels and increased miR‐375 levels in patients with vitiligo. MTT and transwell assays indicated that TUG1 upregulation facilitated melanocyte survival and inhibited CD8 + T cell migration. Dual luciferase reporter and chromatin immunoprecipitation assays verified that Forkhead box O3 (FOXO3) directly interacted with the TUG1 promoter, leading to the positive regulation of TUG1 expression. In addition, FOXO3 promoted melanocyte survival by enhancing the transcription of TUG1. Luciferase reporter assay and RNA immunoprecipitation assay confirmed that TUG1 upregulated GATA binding protein 3 (GATA3) expression by targeting miR‐375. TUG1 facilitated melanocyte survival by regulating the miR‐375/GATA3 axis. In vitiligo, melanocyte survival is promoted by the induction of the TUG1‐mediated miR‐375/GATA3 axis by FOXO3, which offers new therapeutic targets for vitiligo treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI